Risk SNP-induced lncRNA-SLCC1 drives colorectal cancer through activating glycolysis signaling
Tingting Yan,Chaoqin Shen,Penglei Jiang,Chenyang Yu,Fangfang Guo,Xianglong Tian,Xiaoqiang Zhu,Shiyuan Lu,Bingshe Han,Ming Zhong,Jinxian Chen,Qiang Liu,Yingxuan Chen,Junfang Zhang,Jie Hong,Haoyan Chen,Jing-Yuan Fang
DOI: https://doi.org/10.1038/s41392-020-00446-7
IF: 39.3
2021-02-19
Signal Transduction and Targeted Therapy
Abstract:Abstract Long non-coding RNAs (lncRNAs) play key roles in colorectal carcinogenesis. Here, we aimed to identify the risk SNP-induced lncRNAs and to investigate their roles in colorectal carcinogenesis. First, we identified rs6695584 as the causative SNP in 1q41 locus. The A>G mutation of rs6695584 created a protein-binding motif of BATF, altered the enhancer activity, and subsequently activated lncSLCC1 expression. Further validation in two independent CRC cohorts confirmed the upregulation of lncSLCC1 in CRC tissues, and revealed that increased lncSLCC1 expression was associated with poor survival in CRC patients. Mechanistically, lncRNA-SLCC1 interacted with AHR and transcriptionally activated HK2 expression, the crucial enzyme in glucose metabolism, thereby driving the glycolysis pathway and accelerating CRC tumor growth. The functional assays revealed that lncSLCC1 induced glycolysis activation and tumor growth in CRC mediated by HK2. In addition, HK2 was upregulated in colorectal cancer tissues and positively correlated with lncSLCC1 expression and patient survival. Taken together, our findings reveal a risk SNP-mediated oncogene lncRNA-SLCC1 promotes CRC through activating the glycolysis pathway.
biochemistry & molecular biology,cell biology